BlueView

Temperature monitoring for vaccine storage is important. Vaccine inventories exposed to temperature excursions represent a risk to public health, and patient safety and vaccine efficacy may be impacted if vaccines are stored outside the manufacturer’s recommended temperature...

Performing routine preventative maintenance and calibration on professional medical-grade refrigerators and freezers not only provides protection for your most valuable and sensitive medications, vaccines, and patient samples, it also supports regulatory compliance where...

Refrigerators and freezers used in clinical settings to store medications and vaccines or biologics such as blood and patient tissue samples are vital components in ensuring these highly sensitive and highly valuable products and specimens remain safe and effective.

GX Solutions are the first professional medical-grade refrigerators and freezers designed and manufactured to meet the demanding requirements of daily use in pharmacy, clinical laboratory, and blood bank settings.

For the third year in a row, the BD Pyxis™MedStation ES was named the Best in KlasAutomated Dispensing Cabinet (ADC) for 2022 in the annualBest in Klas Software and Professional Service report published by Klas Research.

The World Health Organization (WHO) has published guidance highlighting the importance of temperature mapping all cold storage equipment used to store medications and vaccines. The guidance requires all such equipment should be temperature mapped every two years and after any...

According to the Annual Hospital Pharmacy Operations Report recently published by KitCheck, which surveyed 118 hospital pharmacy professionals (89 percent of whom have worked in the pharmacy hospital space for more than 10 years), the top three technology initiatives hospitals...

The CDC Vaccine Storage and Handling Toolkit provides comprehensive information, recommendations, and resources to assist medical professionals in properly storing and handling vaccine inventory, including cold storage guidance.

The deadline to submit comments related to proposed changes to USP <797> was March 17. This milestone signals the final opportunity for public comment before the chapter is adopted or revised again.

Roughly 15 months after the first COVID-19 vaccine was administered in the U.S., vaccine manufacturers Pfizer and Moderna have submitted requests to the United States Food and Drug Administration (FDA) for approval of a second booster –a fourth dose overall – for certain...